BPA Call HT001424A0002-HT009025FG0210044
Award Date
2/10/25
Potential Completion Date
9/30/25
Potential Value
$22K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $25,261.04, was granted to Sofie CO. (doing business as Sofie) by the Defense Health Agency (DHA) to provide radiopharmaceuticals needed for prostate cancer patients with metastatic lesions. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and an ultimate completion date of September 30, 2025. Sofie is a subsidiary of Sofie Biosciences, Inc., specializing in the development and delivery of molecular diagnostics...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., is for the provision of radiopharmaceuticals to the Defense Health Agency (DHA) and supports medical imaging and cancer treatment programs for the Department of Defense. The $100,000.00 firm-fixed-price contract, which is not set-aside, covers the delivery of various radiopharmaceuticals, including positron emission tomography (PET) imaging agents, prostate cancer detection tools, and injectable cancer drugs....
Sofie CO was awarded a firm fixed price contract by the Defense Health Agency to provide a radiopharmaceutical needed for a prostate cancer patient with metastatic lesions after definitive treatment. The contract has a potential value of $18,367.85 and a period of performance through September 30, 2022. No set-aside designation was used for this award made under the Blanket Purchase Agreement call-ordering procedures. Performance will take place in Sterling, Virginia. The parent company of the...
The Defense Health Agency awarded a firm fixed price blanket purchase agreement call contract valued at $14,434.88 to Sofie CO, doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is to provide a radiopharmaceutical needed for prostate cancer treatment of a patient with metastatic lesions following definitive therapy. Performance will take place in Sterling, Virginia through September 30, 2023. No set aside designation or subcontractors were indicated. The Defense...
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO. for the provision of radiopharmaceuticals. The contract has a firm fixed price and a potential value of $1,765,046.64, with a completion date of April 12, 2024. Sofie CO. is a for-profit organization and the parent company is Sofie Biosciences, Inc. The company has extensive experience in PET imaging and has received numerous federal contract awards from the VA, Defense...
This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,249.48 firm fixed price contract is a BPA call that has an ultimate completion date of March 21, 2025. Sofie is a for-profit organization that specializes in the development, production, and delivery of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals and PET imaging agents. The contract does not have a set-aside...
This is a federal contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, for the delivery of radiopharmaceuticals. The contract, valued at $36,087.20, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price. The contract has a completion date of September 30, 2024. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals, to various...
This is a federal contract award to Sofie CO., doing business as Sofie, to provide nuclear medicine medications. The contract has a ceiling value of $75,000.00 and was awarded by the Defense Health Agency (DHA), a component of the Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call and is for firm fixed-price products. Sofie CO. is a subsidiary of Sofie Biosciences, Inc. and specializes in developing and delivering molecular diagnostics and therapeutics, including...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a firm fixed price contract valued at thirty-four thousand nine hundred sixty dollars by the Defense Health Agency. The contract calls for Sofie to provide a radiopharmaceutical needed for prostate cancer treatment of a patient with metastatic lesions, in support of the Agency's healthcare programs. Performance will occur in Sterling, Virginia with all work completed by September 30, 2023. No set-aside designation was applied...